Tumor-Associated Macrophage Promotes the Survival of Cancer Cells upon Docetaxel Chemotherapy via the CSF1/CSF1R–CXCL12/CXCR4 Axis in Castration-Resistant Prostate Cancer
Castration-resistant prostate cancer (CRPC) is an advanced stage of prostate cancer that can progress rapidly even in patients treated with castration. Previously, we found that tumor-associated macrophages (TAM) can be recruited by CSF-1 secreted by docetaxel-treated prostate cancer cells and promo...
Main Authors: | Wei Guan, Fan Li, Zhenyu Zhao, Zongbiao Zhang, Junhui Hu, Yan Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Genes |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4425/12/5/773 |
Similar Items
-
CXCL12-CXCR4/CXCR7 Axis in Colorectal Cancer: Therapeutic Target in Preclinical and Clinical Studies
by: Tripti Khare, et al.
Published: (2021-07-01) -
CXCL12-CXCR4 axis: its role and the drug inhibitors on each type of cancers
by: A. Zarinkhat, et al.
Published: (2022-07-01) -
Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells
by: Christian Koch, et al.
Published: (2022-12-01) -
CXCL12 MODULATION OF CXCR4 AND CXCR7 ACTIVITY IN HUMAN GLIOBLASTOMA STEM-LIKE CELLS AND REGULATION OF THE TUMOR MICROENVIRONMENT
by: Roberto eWurth, et al.
Published: (2014-05-01) -
IRF5 inhibits prostate cancer metastasis and drug resistance by decreasing CXCR4/CXCL12 complex
by: Ozge Cevik, et al.
Published: (2021-12-01)